GIM
GSK icon

Greylin Investment Management’s GSK GSK Stock Holding History

Greylin Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,524
Closed -$1.66M – 72
2022
Q2 		$1.66M Buy
30,524
+14,132
+86% +$780K 0.32% 36
2022
Q1 		$893K Buy
16,392
+5,652
+53% +$307K 0.15% 43
2021
Q4 		$592K Buy
+10,740
New +$559K 0.11% 58
2018
Q4 		– Sell
-4,100
Closed -$206K – 79
2018
Q3 		$206K Sell
4,100
-11,704
-74% -$595K 0.04% 74
2018
Q2 		$796K Sell
15,804
-8,060
-34% -$406K 0.17% 48
2018
Q1 		$1.17M Sell
23,864
-30,556
-56% -$1.42M 0.25% 43
2017
Q4 		$2.41M Sell
54,420
-34,708
-39% -$1.6M 0.52% 29
2017
Q3 		$4.52M Sell
89,128
-1,724
-2% -$87.5K 1.04% 19
2017
Q2 		$4.9M Sell
90,852
-904
-1% -$48.2K 1.13% 18
2017
Q1 		$4.84M Buy
91,756
+8,244
+10% +$418K 1.12% 17
2016
Q4 		$4.02M Buy
83,512
+39,224
+89% +$1.94M 0.96% 16
2016
Q3 		$2.39M Buy
44,288
+440
+1% +$24.1K 0.6% 23
2016
Q2 		$2.38M Buy
43,848
+1,340
+3% +$70.6K 0.59% 23
2016
Q1 		$2.15M Buy
42,508
+792
+2% +$39.4K 0.56% 24
2015
Q4 		$2.1M Buy
+41,716
New +$2.13M 0.56% 24
2015
Q2 		– Sell
-17,764
Closed -$949K – 60
2015
Q1 		$949K Buy
+17,764
New +$1.02M 0.23% 34

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Greylin Investment Management's GSK Position: Q3 2022 in Review

Greylin Investment Management sold out of GSK (GSK) in Q3 2022, closing a stake of 30,524 shares — an estimated $1.66M sold.

Greylin Investment Management first reported a position in GSK in Q1 2015 and held it in 16 quarters. The position peaked at $4.9M in Q2 2017. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Greylin Investment Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Greylin Investment Management sold 30,524 GSK shares in Q3 2022, an estimated $1.66M.
  • Greylin Investment Management first reported a position in GSK in Q1 2015 and held it in 16 quarters.
  • Greylin Investment Management's GSK position peaked at $4.9M in Q2 2017.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Greylin Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.